In a letter to the editor, Liu et al.
(1) find that PTEN contains some transcript variants that are polyadenylated and prematurely terminated in the first intron of PTEN. These transcripts are suggested to be 5′-UTRcontaining promoter-spanning and to encode for three small RNAs (sRNAs), with one of these (sRNA3) being antisense to oligodeoxynucleotide 2 (ODN2), which was one of two ODNs used to interrogate the molecular dynamics and recruitment of DNA methyltransferase 3a to the PTEN promoter (2) ( Fig. 1 A and  B) . Fascinatingly, such endogenous sRNAs could have the capacity to interact with PTEN pseudogene 1-encoded transcripts (Fig. 1C) , and consequently act as transcriptional regulators of the PTEN gene, where sRNAs as well as long noncoding RNAs cooperate in regulating endogenous expression of PTEN.
While it is feasible that sRNA3 could be involved in regulation of PTEN, possibly through the interaction with PTEN pseudogene 1-encoded antisense transcripts, we note that these transcripts must be expressed in the same tissues for such regulation to take place. Here, we note that Liu et al.
(1) combine 3P-sequencing from 293HEK with sRNA-sequencing from H1-neuron while addressing their predictions in HeLa cells, a cell line where we previously reported low expression of PTEN pseudogene 1-encoded transcripts (3). We suggest that more comprehensive analysis of sRNA3 is needed before making such statements, where, for example, (i) functional loading into Ago2 should be confirmed and Luciferase reporter assays carried out, (ii) 3′-and 5′-RACE is needed to assign the sRNAs to the polyadenylated 5′-UTR-spanning transcript, and (iii) the sensitivity of the oligo (Dt) priming assay for the prematurely terminated PTEN transcript needs further evaluation. At this point, the oligo(dT) priming relies on 25 T residues and two A anchor residues and should be validated for the ability to allow for reverse priming of other transcripts, most importantly full-length PTEN mRNA.
While it is feasible that ODN2, when transfected into 293HEK cells, could interfere with the function and/or maturation of sRNA3 in those studies reported in our paper (2), biotin-linked ODN2 was found to be capable of binding and pulling down the PTEN 5′-UTR-containing transcript ( figure 1E of ref. 2) suggesting, ultimately, that ODN2 directly interacts with the targeted transcript in 293HEK cells. Nonetheless, the findings reported by Liu et al. (1), juxtaposed with previous work (2-4), suggest that the level of RNA-based regulation for the PTEN tumor suppressor gene is more complex than originally appreciated and contains not only a promoter-overlapping 5′-UTR for PTEN but also a sense and antisense pseudogene on chromosome 9 as well as now putative sRNAs expressed from the PTEN locus that may be transcriptional modulators of the PTEN pseudogene. 
